Related references
Note: Only part of the references are listed.Decreasing the immunogenicity of arginine deiminase enzyme via structure-based computational analysis
Mahboubeh Zarei et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity
Sandeep Kumar Dhanda et al.
IMMUNOLOGY (2018)
Detection of Memory B Activity Against a Therapeutic Protein in Treatment-Naive Subjects
Karen Liao et al.
AAPS JOURNAL (2018)
Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins
Ronit Mazor et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Bispecific antibody based therapeutics: Strengths and challenges
Archana Thakur et al.
BLOOD REVIEWS (2018)
Antibodies to watch in 2018
Helene Kaplon et al.
MABS (2018)
A human immune system mouse model with robust lymph node development
Yan Li et al.
NATURE METHODS (2018)
Population-specific design of de-immunized protein biotherapeutics
Benjamin Schubert et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
A Humanized Mouse Model Generated Using Surplus Neonatal Tissue
Matthew E. Brown et al.
STEM CELL REPORTS (2018)
Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions
Abdoelnaser M. Degoot et al.
FRONTIERS IN IMMUNOLOGY (2018)
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab
Anders H. Kverneland et al.
ONCOIMMUNOLOGY (2018)
Predicting Antigen Presentation - What Could We Learn From a Million Peptides?
David Gfeller et al.
FRONTIERS IN IMMUNOLOGY (2018)
Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization
Yann Gallais et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding site
Karin A. van Schie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Insights into immune system development and function from mouse T-cell repertoires
Zachary Sethna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools
Kasper Lamberth et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors
Moustafa Hamze et al.
FRONTIERS IN IMMUNOLOGY (2017)
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
Jenny Link et al.
PLOS ONE (2017)
Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay
Heidi S. Schultz et al.
PLOS ONE (2017)
The state-of-play and future of antibody therapeutics
Zehra Elgundi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
SEPIa, a knowledge-driven algorithm for predicting conformational B-cell epitopes from the amino acid sequence
Georgios A. Dalkas et al.
BMC BIOINFORMATICS (2017)
Evaluating and Reporting the Immunogenicity Impacts for Biological Products-a Clinical Pharmacology Perspective
Yow-Ming C. Wang et al.
AAPS JOURNAL (2016)
Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody
L. Xue et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Immunogenicity of long-lasting recombinant factor VIII products
Mathieu Ing et al.
CELLULAR IMMUNOLOGY (2016)
From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals
G. R. Gunn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Nanobodies as therapeutics: big opportunities for small antibodies
Sophie Steeland et al.
DRUG DISCOVERY TODAY (2016)
CD4+T-cell epitope prediction using antigen processing constraints
Ramgopal R. Mettu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates
Mohadeseh Haji Abdolvahab et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2016)
Managing unwanted immunogenicity of biologicals
Maureen Deehan et al.
AUTOIMMUNITY REVIEWS (2015)
Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products
Liusong Yin et al.
CELLULAR IMMUNOLOGY (2015)
Depletion of T Cell Epitopes in Lysostaphin Mitigates Anti-Drug Antibody Response and Enhances Antibacterial Efficacy In Vivo
Hongliang Zhao et al.
CHEMISTRY & BIOLOGY (2015)
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
B. Rup et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Determinants of immunodominance for CD4 T cells
AeRyon Kim et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis
Krista G. Haanstra et al.
JOURNAL OF IMMUNOLOGY (2015)
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis
Michael J. Turner et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Assessment of the Immunogenicity of Mechanically Induced Interferon Aggregates in a Transgenic Mouse Model
Paul Human et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
Arne Homann et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys
S. Dudal et al.
MABS (2015)
The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse Model
Juliana Bessa et al.
PHARMACEUTICAL RESEARCH (2015)
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
Sue Townsend et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Danger signal-dependent activation of human dendritic cells by plasma-derived factor VIII products
Lilija Miller et al.
THROMBOSIS AND HAEMOSTASIS (2015)
T follicular regulatory cells in the regulation of B cell responses
Peter T. Sage et al.
TRENDS IN IMMUNOLOGY (2015)
The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling
Liusong Yin et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
K. A. van Schie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model
Ernesto Luna et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2015)
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
Bernd C. Kieseier et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Pharmacokinetics and Immunogenicity Investigation of a Human Anti-Interleukin-17 Monoclonal Antibody in Non-Naive Cynomolgus Monkeys
Chao Han et al.
DRUG METABOLISM AND DISPOSITION (2015)
Dynamics of B cells in germinal centres
Nilushi S. De Silva et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides-Harmonized Terminology and Tactical Recommendations
G. Shankar et al.
AAPS JOURNAL (2014)
A modified immune tolerant mouse model to study the immunogenicity of recombinant human interferon beta
Mohadeseh Haji Abdolvahab et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Biopharmaceutical benchmarks 2014
Gary Walsh
NATURE BIOTECHNOLOGY (2014)
Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro
Verena Rombach-Riegraf et al.
PLOS ONE (2014)
A Mechanistic, Multiscale Mathematical Model of Immunogenicity for Therapeutic Proteins: Part 2-Model Applications
X. Chen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics
Lei Zhou et al.
AAPS JOURNAL (2013)
Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine
Anthony Rongvaux et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Evaluating the Immunogenicity of Protein Drugs by Applying In Vitro MHC Binding Data and the Immune Epitope Database and Analysis Resource
Sinu Paul et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels
L. Semerano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Systems Pharmacology for Drug Discovery and Development: Paradigm Shift or Flash in the Pan?
P. Vicini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases
C. C. Mok et al.
CLINICAL RHEUMATOLOGY (2013)
Differential immunogenicity and allergenicity of native and recombinant human lactoferrins: Role of glycosylation
Rachael J. Almond et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Soluble human CD83 ameliorates lupus in NZB/W F1 mice
Charlotte Starke et al.
IMMUNOBIOLOGY (2013)
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
Krista G. Haanstra et al.
JOURNAL OF IMMUNOLOGY (2013)
Development of a Human Antibody Tolerant Mouse Model to Assess the Immunogenicity Risk Due to Aggregated Biotherapeutics
Vivian Bi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
Peter J. K. van Meer et al.
MABS (2013)
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
Pauline A. van Schouwenburg et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Development of a Transgenic Mouse Model with Immune Tolerance for Human Coagulation Factor VIIa
Christine Lenk et al.
PHARMACEUTICAL RESEARCH (2013)
Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions Systematic Review and Meta-analysis
Jose Ramon Maneiro et al.
JAMA INTERNAL MEDICINE (2013)
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Narendra Chirmule et al.
AAPS JOURNAL (2012)
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice
Katharina N. Steinitz et al.
BLOOD (2012)
Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo
Leonard Moise et al.
CLINICAL IMMUNOLOGY (2012)
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a
C. Scagnolari et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Relationship between potential aggregation-prone regions and HLA-DR-binding T-cell immune epitopes: Implications for rational design of novel and follow-on therapeutic antibodies
Sandeep Kumar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Interchangeability, immunogenicity and biosimilars
Hans C. Ebbers et al.
NATURE BIOTECHNOLOGY (2012)
Antibody Repertoires in Humanized NOD-scid-IL2Rγnull Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse
Gregory C. Ippolito et al.
PLOS ONE (2012)
Humanized mice for immune system investigation: progress, promise and challenges
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay
Clare F. J. Grant et al.
VETERINARY RESEARCH (2012)
Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model
Pauline M. van Helden et al.
BLOOD (2011)
Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors
Stephanie Delluc et al.
FASEB JOURNAL (2011)
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Satish Kumar Singh
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells
Rebecca Danner et al.
PLOS ONE (2011)
Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm
Anna Lena Woelke et al.
PLOS ONE (2011)
Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions
Sandeep Kumar et al.
PHARMACEUTICAL RESEARCH (2011)
Immunogenicity of Therapeutic Proteins: The Use of Animal Models
Vera Brinks et al.
PHARMACEUTICAL RESEARCH (2011)
Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo
Nicolas Legrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
A. Vultaggio et al.
ALLERGY (2010)
Quantification of the preexisting CD4 T-cell repertoire specific for human erythropoietin reveals its immunogenicity potential
Stephanie Delluc et al.
BLOOD (2010)
Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
Danika Wullner et al.
CLINICAL IMMUNOLOGY (2010)
Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta
Miranda M. C. van Beers et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Optimization of a dendritic cell-based assay for the in vitro priming of naive human CD4+ T cells
Janice M. Moser et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
The immunogenicity of humanized and fully human antibodies Residual immunogenicity resides in the CDR regions
Fiona A. Harding et al.
MABS (2010)
ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale
Mark Halling-Brown et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2010)
Opportunities and limitations of mouse models humanized for HLA class II antigens
B. M. Reipert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
A. Pavlova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Experimental models to study development and function of the human immune system in vivo
N Legrand et al.
JOURNAL OF IMMUNOLOGY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2005)
The kinetic stability of MHC class II: Peptide complexes is a key parameter that dictates immunodominance
CA Lazarski et al.
IMMUNITY (2005)
Rationally engineered therapeutic proteins with reduced immunogenicity
S Tangri et al.
JOURNAL OF IMMUNOLOGY (2005)
Humanized animal models for autoimmune diseases
JW Gregersen et al.
TISSUE ANTIGENS (2004)
PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates
ZJ Yang et al.
CANCER RESEARCH (2004)
A mouse model of human adaptive immune functions:: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice
A Pajot et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Inhibitors in haemophilia: pathophysiology
JMR Saint-Remy et al.
HAEMOPHILIA (2004)
Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains
AB Vogt et al.
IMMUNOLOGICAL REVIEWS (2002)
Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP
B Manoury et al.
NATURE IMMUNOLOGY (2002)
CD4+ T-cell epitope determination using unexposed human donor peripheral blood mononuclear cells
MM Stickler et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice
RS Abraham et al.
CURRENT OPINION IN IMMUNOLOGY (2000)
Share Paper
